Latest News and Press Releases
Want to stay updated on the latest news?
-
SAN DIEGO, CA, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (“EHP” or the “Company”), a clinical-stage biopharmaceutical company developing a new class of medicines to treat...
-
Data published in peer-reviewed journal confirms novel mechanism of action SAN DIEGO, CA, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (“EHP” or the “Company”), a...
-
SAN DIEGO, CA, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (“EHP” or the “Company”), a clinical-stage biopharmaceutical company developing a new class of medicines to...
-
SAN DIEGO, CA, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Further to its news release on July 11, 2022, Emerald Health Pharmaceuticals Inc. (“EHP” or the “Company”) has reached a settlement (the...
-
SAN DIEGO, CA, July 11, 2022 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (EHP or the Company), a clinical-stage biopharmaceutical company developing a new class of medicines to treat...
-
SAN DIEGO, CA, April 05, 2022 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (EHP or the Company), a clinical-stage biopharmaceutical company developing a new class of medicines to treat...
-
SAN DIEGO, CA, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (EHP or the Company), a clinical-stage biopharmaceutical company developing a new class of medicines to treat...
-
SAN DIEGO, CA, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (EHP or the Company), a clinical-stage biopharmaceutical company developing a new class of medicines to treat...
-
Data published in peer-reviewed journal show ability of EHP-101 to prevent cardiac, renal, pulmonary and dermal fibrosis SAN DIEGO, CA, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Emerald Health...
-
SAN DIEGO, CA, May 24, 2021 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (EHP or the Company), a clinical-stage biotechnology company developing a new class of medicines to treat...